|
1
|
Twait EL, Gerritsen L, Moonen JE, Verberk IM, Teunissen CE, Visser PJ, van der Flier WM, Geerlings MI. Association between plasma Alzheimer’s disease markers and MRI markers of cerebral small vessel disease and neurodegeneration: the SMART‐MR Study. Alzheimers Dement 2022. [DOI: 10.1002/alz.067876] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Emma L. Twait
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University Utrecht Netherlands
| | | | - Justine E. Moonen
- Alzheimer Center, Vrije Universiteit Amsterdam, UMC, Amsterdam Amsterdam Netherlands
| | - Inge M.W. Verberk
- Neurochemistry Laboratory, Neuroscience, Amsterdam University Medical Center, Amsterdam Amsterdam Netherlands
| | - Charlotte E. Teunissen
- Neurochemistry Laboratory, Neuroscience, Amsterdam University Medical Center, Amsterdam Amsterdam Netherlands
| | - Pieter Jelle Visser
- Alzheimer Center, Vrije Universiteit Amsterdam, UMC, Amsterdam Amsterdam Netherlands
| | | | - Mirjam I. Geerlings
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University Utrecht Netherlands
| | | |
Collapse
|
|
2
|
den Braber A, Verberk IM, Tomassen J, Coomans EM, van der Landen SM, Boonkamp L, Dage JL, Stoops E, Willemsen G, Nivard MG, van Berckel BNM, Scheltens P, Visser PJ, de Geus EJ, Teunissen CE. Value of plasma biomarkers to predict memory change in cognitively unimpaired individuals. Alzheimers Dement 2022. [DOI: 10.1002/alz.061795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Anouk den Braber
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
- Department of Biological Psychology, Vrije Universiteit Amsterdam Amsterdam Netherlands
| | - Inge M.W. Verberk
- Neurochemistry Laboratory, Department of Clinical Chemistry Neuroscience, Vrije Universiteit Amsterdam UMC, Amsterdam Amsterdam Amsterdam Netherlands
| | - Jori Tomassen
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Emma M Coomans
- Department of Radiology & Nuclear Medicine Neuroscience, Vrije Universiteit Amsterdam UMC, Amsterdam Amsterdam Amsterdam Netherlands
| | - Sophie M van der Landen
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Lynn Boonkamp
- Neurochemistry Laboratory, Department of Clinical Chemistry Neuroscience, Vrije Universiteit Amsterdam UMC, Amsterdam Amsterdam Amsterdam Netherlands
| | - Jeffrey L. Dage
- Stark Neurosciences Research Institute, Indiana University School of Medicine Indianapolis IN USA
| | - Erik Stoops
- ADx NeuroSciences NV, Technologiepark 94 Ghent 9052 Belgium
| | - Gonneke Willemsen
- Department of Biological Psychology, Vrije Universiteit Amsterdam Amsterdam Netherlands
| | - Michel G. Nivard
- Department of Biological Psychology, Vrije Universiteit Amsterdam Amsterdam Netherlands
| | - Bart NM van Berckel
- Department of Radiology & Nuclear Medicine Neuroscience, Vrije Universiteit Amsterdam UMC, Amsterdam Amsterdam Amsterdam Netherlands
| | - Philip Scheltens
- Alzheimer Center Amsterdam, Neurology Neuroscience, Vrije Universiteit Amsterdam UMC, Amsterdam Amsterdam Amsterdam Netherlands
| | - Pieter Jelle Visser
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
- Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University Maastricht Netherlands
- Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet Stockholm Sweden
| | - Eco J.C. de Geus
- Department of Biological Psychology, Vrije Universiteit Amsterdam Amsterdam Netherlands
| | - Charlotte E. Teunissen
- Neurochemistry Laboratory, Department of Clinical Chemistry Neuroscience, Vrije Universiteit Amsterdam UMC, Amsterdam Amsterdam Amsterdam Netherlands
| |
Collapse
|
|
3
|
Honey MIJ, Verberk IM, Gouda M, Hussainali Z, Kroeze LA, van Leeuwenstijn M, Mank A, Trieu C, Wilson D, Pijnenburg YA, van der Flier WM, van Harten AC, Teunissen CE. Plasma glial fibrillary acidic protein, neurofilament light, phosphorylated‐tau‐181 and amyloid β
42/40
as prognostic biomarkers for clinical progression to dementia in individuals with subjective cognitive decline and mild cognitive impairment. Alzheimers Dement 2022. [DOI: 10.1002/alz.064620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Madison I. J. Honey
- Neurochemistry Laboratory, Department of Clinical Chemistry, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
| | - Inge M.W. Verberk
- Neurochemistry Laboratory, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, Netherlands
| | - Mariam Gouda
- Neurochemistry Laboratory, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, Netherlands
| | - Zulaiga Hussainali
- Neurochemistry Laboratory, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, Netherlands
| | - Lior A. Kroeze
- Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
| | - Mardou van Leeuwenstijn
- Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
| | - Arenda Mank
- Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
| | - Calvin Trieu
- Neurochemistry Laboratory, Department of Clinical Chemistry, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
- Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
| | | | - Yolande A.L. Pijnenburg
- Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
| | - Wiesje M. van der Flier
- Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
| | - Argonde C. van Harten
- Neurochemistry Laboratory, Department of Clinical Chemistry, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
- Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
| | - Charlotte E. Teunissen
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
| |
Collapse
|
|
4
|
Verberk IM, van Harten AC, Gouda M, Hussainali Z, van Engelen ME, Wilson D, Lemstra AW, Pijnenburg YA, van der Flier WM, Teunissen CE. Implementation of the Alzheimer’s blood‐based biomarker panel in clinical practice: the development of cutoffs for plasma Abeta
1‐42/1‐40
, P‐tau181, GFAP and NfL across the clinical continuum. Alzheimers Dement 2022. [DOI: 10.1002/alz.064069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Inge M.W. Verberk
- Neurochemistry Laboratory, Amsterdam Neuroscience, Amsterdam University Medical Center Amsterdam Netherlands
| | - Argonde C. van Harten
- Alzheimer Center Amsterdam Neuroscience, Vrije Universiteit Amsterdam UMC, Amsterdam Amsterdam Amsterdam Netherlands
| | - Mariam Gouda
- Neurochemistry Laboratory, Amsterdam Neuroscience, Amsterdam University Medical Center Amsterdam Netherlands
| | - Zulaiga Hussainali
- Neurochemistry Laboratory, Amsterdam Neuroscience, Amsterdam University Medical Center Amsterdam Netherlands
| | - Marie‐Paule E. van Engelen
- Alzheimer Center Amsterdam, Department of Neurology Neuroscience, Vrije Universiteit Amsterdam UMC, Amsterdam Amsterdam Amsterdam Netherlands
| | | | - Afina W. Lemstra
- Alzheimer Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam UMC Amsterdam Amsterdam Netherlands
| | - Yolande A.L. Pijnenburg
- Alzheimer Center Amsterdam Neuroscience, Vrije Universiteit Amsterdam UMC, Amsterdam Amsterdam Amsterdam Netherlands
| | - Wiesje M. van der Flier
- Alzheimer Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam UMC Amsterdam Amsterdam Netherlands
| | - Charlotte E. Teunissen
- Neurochemistry Laboratory, Amsterdam Neuroscience, Amsterdam University Medical Center Amsterdam Netherlands
| |
Collapse
|
|
5
|
Honey MIJ, Wesenhagen KEJ, Willemse EA, Verberk IM, Boonkamp L, Killestein J, Visser PJ, Tijms BM, Teunissen CE. Comparison between plasma, serum and cerebrospinal fluid glial fibrillary acidic protein in Alzheimer’s Disease and Dementia with Lewy bodies and the effect of age and sex on diagnostic performance. Alzheimers Dement 2022. [DOI: 10.1002/alz.067313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Madison I. J. Honey
- Neurochemistry Laboratory, Department of Clinical Chemistry, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Kirsten E. J. Wesenhagen
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Eline A.J. Willemse
- Neurochemistry Laboratory, Department of Clinical Chemistry, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
- University Hospital Basel and University of Basel, Department Of Neurology, Departments Of Biomedicine And Clinical Research Basel Switzerland
| | - Inge M.W. Verberk
- Neurochemistry Laboratory, Department of Clinical Chemistry, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Lynn Boonkamp
- Neurochemistry Laboratory, Department of Clinical Chemistry, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Joep Killestein
- MS Center Amsterdam, Department of Neurology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam Neuroscience Amsterdam Netherlands
| | - Pieter Jelle Visser
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
- Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet Stockholm Sweden
- Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University Maastricht Netherlands
| | - Betty M. Tijms
- Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Charlotte E. Teunissen
- Neurochemistry Laboratory, Department of Clinical Chemistry, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| |
Collapse
|
|
6
|
Janelidze S, Palmqvist S, Leuzy A, Stomrud E, Verberk IM, Zetterberg H, Ashton NJ, Mattsson‐Carlgren N, Pesini P, Sarasa L, Allué JA, Teunissen CE, Dage JL, Blennow K, Hansson O. Detecting amyloid positivity in early Alzheimer disease using plasma biomarkers. Alzheimers Dement 2021. [DOI: 10.1002/alz.052117] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
| | - Sebastian Palmqvist
- Lund University Lund Sweden
- Memory Clinic, Skåne University Hospital Malmö Sweden
| | | | - Erik Stomrud
- Lund University Lund Sweden
- Memory Clinic, Skåne University Hospital Malmö Sweden
| | - Inge M.W. Verberk
- Neurochemistry Laboratory, Department of Clinical Chemistry, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Henrik Zetterberg
- Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg Mölndal Sweden
- Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital Mölndal Sweden
- Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square London United Kingdom
- UK Dementia Research Institute Fluid Biomarkers Laboratory, UK DRI at UCL London United Kingdom
| | - Nicholas J. Ashton
- NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation London United Kingdom
- Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg Gothenburg Sweden
- King's College London London United Kingdom
- Institute of Physiology and Neuroscience, University of Gothenburg Mölndal Sweden
| | | | | | | | | | - Charlotte E. Teunissen
- Neurochemistry Lab, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC Amsterdam Amsterdam Netherlands
| | | | - Kaj Blennow
- Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital Mölndal Sweden
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg Mölndal Sweden
| | - Oskar Hansson
- Lund University Lund Sweden
- Memory Clinic, Skåne University Hospital Malmö Sweden
| |
Collapse
|
|
7
|
den Braber A, Verberk IM, Den Dulk B, Tomassen J, Dage JL, Stoops E, Willemsen G, Nivard MG, Van Berckel BN, Scheltens P, Visser PJ, de Geus EJ, Teunissen CE. Plasma P‐tau181 levels predict amyloid pathology in cognitively unimpaired individuals after 10 years. Alzheimers Dement 2021. [DOI: 10.1002/alz.051727] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Anouk den Braber
- Department of Biological Psychology Vrije Universiteit Amsterdam Amsterdam Netherlands
- Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Inge M.W. Verberk
- Neurochemistry Laboratory Department of Clinical Chemistry Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Ben Den Dulk
- Neurochemistry Laboratory Department of Clinical Chemistry Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Jori Tomassen
- Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | | | | | - Gonneke Willemsen
- Department of Biological Psychology Vrije Universiteit Amsterdam Amsterdam Netherlands
| | - Michel G. Nivard
- Department of Biological Psychology Vrije Universiteit Amsterdam Amsterdam Netherlands
| | - Bart N.M. Van Berckel
- Department of Radiology & Nuclear Medicine Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Philip Scheltens
- Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Pieter Jelle Visser
- Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
- Alzheimer Center Limburg School for Mental Health and Neuroscience Maastricht University Maastricht Netherlands
- Department of Neurobiology Care Sciences and Society Division of Neurogeriatrics Karolinska Institutet Stockholm Sweden
| | - Eco J.C. de Geus
- Department of Biological Psychology Vrije Universiteit Amsterdam Amsterdam Netherlands
| | - Charlotte E. Teunissen
- Neurochemistry Laboratory Department of Clinical Chemistry Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| |
Collapse
|
|
8
|
Ebenau JL, Verberk IM, Verfaillie SC, van den Bosch KA, Scheltens P, Prins ND, Barkhof F, Van Berckel BN, Teunissen CE, van der Flier WM. How to define ‘N’ in the ATN classification in subjective cognitive decline: The SCIENCe project. Alzheimers Dement 2021. [DOI: 10.1002/alz.055891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Jarith L. Ebenau
- Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Inge M.W. Verberk
- Neurochemistry Laboratory Department of Clinical Chemistry Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Sander C.J. Verfaillie
- Department of Radiology & Nuclear Medicine Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Karlijn A. van den Bosch
- Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | | | - Niels D. Prins
- Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Frederik Barkhof
- Department of Radiology and Nuclear Medicine Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Bary N.M. Van Berckel
- Department of Radiology & Nuclear Medicine Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Charlotte E. Teunissen
- Neurochemistry Laboratory Department of Clinical Chemistry Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Wiesje M. van der Flier
- Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| |
Collapse
|
|
9
|
Verberk IM, Misdorp EO, Koelewijn J, Ball AJ, Blennow K, Dage JL, Fandos N, Hansson O, Hirtz C, Janelidze S, Lee R, Rissman RA, Shan D, Shaw LM, Yarasheski KE, Zetterberg H, Edelmayer RM, Teunissen CE. Stability of the novel blood‐based biomarkers under pre‐analytical sample handling conditions: Results of the SABB‐GBSC working group. Alzheimers Dement 2021. [DOI: 10.1002/alz.055441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Inge M.W. Verberk
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Els O. Misdorp
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Jannet Koelewijn
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | | | - Kaj Blennow
- Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg Mölndal Sweden
| | | | | | - Oskar Hansson
- Clinical Memory Research Unit, Lund University Lund Sweden
| | - Christophe Hirtz
- IRMB‐LBPC/PPC, INM, Univ Montpellier, CHU Montpellier, INSERM CNRS Montpellier France
| | | | - Ryan Lee
- PeopleBio Inc. Seongnam South Korea
| | - Robert A. Rissman
- Department of Neurosciences, University of California San Diego La Jolla CA USA
| | | | - Leslie M. Shaw
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania Philadelphia PA USA
| | | | - Henrik Zetterberg
- Institute of Physiology and Neuroscience, University of Gothenburg Mölndal Sweden
| | | | - Charlotte E. Teunissen
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| |
Collapse
|
|
10
|
Ebenau JL, van der Lee SJ, Hulsman M, Tesi N, Jansen IE, Verberk IM, van Leeuwenstijn M, Teunissen CE, Barkhof F, Prins ND, Scheltens P, Holstege H, van Berckel BN, van der Flier WM. Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score. Alzheimers Dement (Amst) 2021; 13:e12229. [PMID: 34541285 PMCID: PMC8438688 DOI: 10.1002/dad2.12229] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/06/2021] [Revised: 06/09/2021] [Accepted: 06/28/2021] [Indexed: 12/22/2022]
Abstract
INTRODUCTION We investigated relationships among genetic determinants of Alzheimer's disease (AD), amyloid/tau/neurodegenaration (ATN) biomarkers, and risk of dementia. METHODS We studied cognitively normal individuals with subjective cognitive decline (SCD) from the Amsterdam Dementia Cohort and SCIENCe project. We examined associations between genetic variants and ATN biomarkers, and evaluated their predictive value for incident dementia. A polygenic risk score (PRS) was calculated based on 39 genetic variants. The APOE gene was not included in the PRS and was analyzed separately. RESULTS The PRS and APOE ε4 were associated with amyloid-positive ATN profiles, and APOE ε4 additionally with isolated increased tau (A-T+N-). A high PRS and APOE ε4 separately predicted AD dementia. Combined, a high PRS increased while a low PRS attenuated the risk associated with ε4 carriers. DISCUSSION Genetic variants beyond APOE are clinically relevant and contribute to the pathophysiology of AD. In the future, a PRS might be used in individualized risk profiling.
Collapse
Affiliation(s)
- Jarith L. Ebenau
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
| | - Sven J. van der Lee
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
- Department of Clinical GeneticsAmsterdam UMCAmsterdamthe Netherlands
| | - Marc Hulsman
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
- Department of Clinical GeneticsAmsterdam UMCAmsterdamthe Netherlands
- Delft Bioinformatics LabDelft University of TechnologyDelftthe Netherlands
| | - Niccolò Tesi
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
- Department of Clinical GeneticsAmsterdam UMCAmsterdamthe Netherlands
- Delft Bioinformatics LabDelft University of TechnologyDelftthe Netherlands
| | - Iris E. Jansen
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
- Department of Complex Trait GeneticsCenter for Neurogenomics and Cognitive ResearchAmsterdam NeuroscienceVU UniversityAmsterdamthe Netherlands
| | - Inge M.W. Verberk
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
- Neurochemistry LaboratoryDepartment of Clinical ChemistryVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
| | - Mardou van Leeuwenstijn
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
| | - Charlotte E. Teunissen
- Neurochemistry LaboratoryDepartment of Clinical ChemistryVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
| | - Frederik Barkhof
- Department of Radiology & Nuclear MedicineAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
- Queen Square Institute of Neurology and Centre for Medical Image ComputingUniversity College LondonLondonUK
| | - Niels D. Prins
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
| | - Philip Scheltens
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
| | - Henne Holstege
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
- Department of Clinical GeneticsAmsterdam UMCAmsterdamthe Netherlands
- Delft Bioinformatics LabDelft University of TechnologyDelftthe Netherlands
| | - Bart N.M. van Berckel
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
- Department of Radiology & Nuclear MedicineAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
| | - Wiesje M. van der Flier
- Alzheimer Center AmsterdamDepartment of NeurologyAmsterdam NeuroscienceVrije Universiteit AmsterdamAmsterdam UMCAmsterdamthe Netherlands
- Department of Epidemiology and BiostatisticsAmsterdam UMCAmsterdamthe Netherlands
| |
Collapse
|
|
11
|
Affiliation(s)
- Elisabeth H. Thijssen
- Neurochemistry Laboratory Department of Clinical Chemistry Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam Netherlands
| | - Inge M.W. Verberk
- Alzheimer Center Amsterdam Department of Neurology Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam Netherlands
| | | | - Adam L. Boxer
- University of California San Francisco San Francisco CA USA
| | - Charlotte E. Teunissen
- Neurochemistry Lab and Biobank Department of Clinical Chemistry Amsterdam Neuroscience Amsterdam UMC Amsterdam Netherlands
| |
Collapse
|
|
12
|
van der Lee SJ, Ebenau JL, Jansen IE, Verberk IM, Scheltens P, Teunissen CE, Barkhof F, Reinders MJ, Van Berckel BN, Holstege H, van Der Flier W. Polygenic risk score for Alzheimer’s disease is related to amyloid positivity in subjective cognitive decline: The SCIENCe project. Alzheimers Dement 2020. [DOI: 10.1002/alz.042116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
| | - Jarith L. Ebenau
- Alzheimer Center Amsterdam Department of Neurology Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | | | - Inge M.W. Verberk
- Alzheimer Center Amsterdam Department of Neurology Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Philip Scheltens
- Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Charlotte E. Teunissen
- Neurochemistry Laboratory and Biobank Department of Clinical Chemistry Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Frederik Barkhof
- Department of Computer Science and Centre for Medical Image Computing University College London London United Kingdom
| | | | | | | | | |
Collapse
|
|
13
|
den Braber A, Verberk IM, Tomassen J, Stoops E, Mauroo K, Willemsen G, Nivard MG, Van Berckel BN, Scheltens P, Visser PJ, de Geus EJ, Teunissen CE. Plasma biomarkers predict amyloid pathology in cognitively unimpaired individuals. Alzheimers Dement 2020. [DOI: 10.1002/alz.045470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Anouk den Braber
- Department of Biological Psychology Vrije Universiteit Amsterdam Amsterdam Netherlands
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Inge M.W. Verberk
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience Vrije Universiteit AmstCam, Amsterdam UMC Amsterdam Netherlands
| | - Jori Tomassen
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | | | | | - Gonneke Willemsen
- Department of Biological Psychology Vrije Universiteit Amsterdam Amsterdam Netherlands
| | - Michel G. Nivard
- Department of Biological Psychology Vrije Universiteit Amsterdam Amsterdam Netherlands
| | - Bart N.M. Van Berckel
- Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Philip Scheltens
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Pieter Jelle Visser
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
- Alzheimer Center Limburg, School for Mental Health and Neuroscience Maastricht University Maastricht Netherlands
- Department of Neurobiology, Care Sciences and Society Division of Neurogeriatrics, Karolinska Institutet Stockholm Sweden
| | - Eco J.C. de Geus
- Department of Biological Psychology Vrije Universiteit Amsterdam Amsterdam Netherlands
| | - Charlotte E. Teunissen
- Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| |
Collapse
|
|
14
|
Shan D, Holdridge M, Chang L, Stoops E, Verberk IM, van Der Flier W, Teunissen CE, Ball AJ. Development of an ultrasensitive multiplex assay for simultaneous detection of Aβ1‐42, Aβ1‐40, GFAP and NF‐L in blood. Alzheimers Dement 2020. [DOI: 10.1002/alz.043506] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
| | | | - Lei Chang
- Quanterix Corporation Lexington MA USA
| | | | - Inge M.W. Verberk
- Alzheimer Center Amsterdam, Department of Neurology Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam Netherlands
| | - Wiesje van Der Flier
- Alzheimer Center Amsterdam, Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam Netherlands
| | | | | |
Collapse
|
|
15
|
Verberk IM, Laarhuis MB, van den Bosch KA, Ebenau JL, Leeuwenstijn M, Wesselman LM, Prins ND, Scheltens P, Teunissen CE, van Der Flier W. Serum glial fibrillary acidic protein and neurofilament light as prognostic biomarkers for clinical progression in subjective cognitive decline: The SCIENCe project. Alzheimers Dement 2020. [DOI: 10.1002/alz.044783] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Inge M.W. Verberk
- Alzheimer Center Amsterdam, Department of Neurology Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
- Neurochemistry Laboratory Department of Clinical Chemistry Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Malika B Laarhuis
- Alzheimer Center Amsterdam, Department of Neurology Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Karlijn A. van den Bosch
- Alzheimer Center Amsterdam, Department of Neurology Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Jarith L. Ebenau
- Alzheimer Center Amsterdam, Department of Neurology Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Mardou Leeuwenstijn
- Alzheimer Center Amsterdam, Department of Neurology Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Linda M.P. Wesselman
- Alzheimer Center Amsterdam, Department of Neurology Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Niels D. Prins
- Alzheimer Center Amsterdam, Department of Neurology Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
- Brain Research Center Amsterdam Netherlands
| | - Philip Scheltens
- Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Charlotte E. Teunissen
- Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Wiesje van Der Flier
- Alzheimer Center Amsterdam, Department of Neurology Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| |
Collapse
|
|
16
|
van den Bosch KA, Verberk IM, Ebenau J, van der Lee SJ, Jansen IE, Prins ND, Scheltens P, Teunissen CE, van Der Flier W. BDNF‐Met polymorphism on top of amyloid pathology predisposes for faster cognitive decline in cognitively normal elderly: The SCIENCe Project. Alzheimers Dement 2020. [DOI: 10.1002/alz.042728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - Inge M.W. Verberk
- Alzheimer Center Amsterdam Department of Neurology Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam Netherlands
| | | | | | - Iris E. Jansen
- Department of Complex Trait Genetics Center for Neurogenomics and Cognitive Research Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam Netherlands
| | | | - Philip Scheltens
- Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam Netherlands
| | | | | |
Collapse
|
|
17
|
De Meyer S, Schaeverbeke J, Gille B, Verberk IM, Luckett ES, Thijssen EH, Gabel S, Mauroo K, Bruffaerts R, Stoops E, Vanderstichele HM, Teunissen CE, Vandenberghe R, Poesen K. Comparison of two analytical platforms for blood‐based surrogate biomarkers of amyloid pathology. Alzheimers Dement 2020. [DOI: 10.1002/alz.045110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Steffi De Meyer
- Laboratory for Molecular Neurobiomarker Research (LaMoN), Department of Neurosciences, Leuven Brain Institute KU Leuven Leuven Belgium
- Laboratory Medicine UZ Leuven Leuven Belgium
| | - Jolien Schaeverbeke
- Laboratory for Cognitive Neurology, Department of Neurosciences KU Leuven Leuven Belgium
- Alzheimer Research Centre KU Leuven Leuven Brain Institute Leuven Belgium
| | - Benjamin Gille
- Laboratory for Molecular Neurobiomarker Research (LaMoN) Leuven Belgium
| | - Inge M.W. Verberk
- Alzheimer Center Amsterdam, Department of Neurology Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam Netherlands
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam Netherlands
| | - Emma Susanne Luckett
- Laboratory for Cognitive Neurology, Department of Neurosciences KU Leuven Leuven Belgium
- Alzheimer Research Centre KU Leuven Leuven Brain Institute Leuven Belgium
| | - Elisabeth H. Thijssen
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam Netherlands
- UCSF Memory and Aging Center San Francisco CA USA
| | - Silvy Gabel
- Laboratory for Cognitive Neurology, Department of Neurosciences KU Leuven Leuven Belgium
- Alzheimer Research Centre KU Leuven Leuven Brain Institute Leuven Belgium
| | | | - Rose Bruffaerts
- Laboratory for Cognitive Neurology, Department of Neurosciences KU Leuven Leuven Belgium
- Neurology Department University Hospitals Leuven (UZ Leuven, Campus Gasthuisberg) Leuven Belgium
| | | | | | - Charlotte E. Teunissen
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam Netherlands
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC Vrije Universiteit Amsterdam Netherlands Amsterdam Netherlands
| | - Rik Vandenberghe
- Laboratory for Cognitive Neurology, Department of Neurosciences KU Leuven Leuven Belgium
- Alzheimer Research Centre KU Leuven Leuven Brain Institute Leuven Belgium
- Neurology Department University Hospitals Leuven (UZ Leuven, Campus Gasthuisberg) Leuven Belgium
| | - Koen Poesen
- Laboratory for Molecular Neurobiomarker Research (LaMoN), Department of Neurosciences, Leuven Brain Institute KU Leuven Leuven Belgium
- Laboratory Medicine UZ Leuven Leuven Belgium
- Alzheimer Research Centre KU Leuven Leuven Brain Institute Leuven Belgium
| |
Collapse
|
|
18
|
Verberk IM, Misdorp EO, Koelewijn JMW, Shan D, Lambrechts C, Shaw LM, Rissman RA, Blennow K, Zetterberg H, Ball AJ, Edelmayer RM, Teunissen CE. A biorepository for the in‐depth validation of pre‐analytical sample handling effects on novel blood‐based biomarkers for Alzheimer’s disease: The first results. Alzheimers Dement 2020. [DOI: 10.1002/alz.045763] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Inge M.W. Verberk
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Els O. Misdorp
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Jannet MW Koelewijn
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | | | | | - Leslie M. Shaw
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine University of Pennsylvania Philadelphia PA USA
| | - Robert A. Rissman
- Department of Neurosciences University of California San Diego La Jolla CA USA
| | - Kaj Blennow
- The Sahlgrenska Academy at the University of Gothenburg Mölndal Sweden
| | - Henrik Zetterberg
- The Sahlgrenska Academy at the University of Gothenburg Mölndal Sweden
| | | | | | - Charlotte E. Teunissen
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| |
Collapse
|
|
19
|
Ebenau J, Timmers T, Wesselman LM, Verberk IM, Verfaillie SC, Slot RE, Teunissen CE, Barkhof F, van den Bosch K, van Leeuwenstijn M, Prins ND, Sikkes SA, Scheltens P, Van Berckel BN, van der Flier WM. F1‐04‐03: ATN BIOMARKER MODEL AS A DETERMINANT OF COGNITIVE DECLINE AND INCIDENT CLINICAL PROGRESSION IN SUBJECTIVE COGNITIVE DECLINE: THE SCIENCE PROJECT. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.4383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
| | | | | | - Inge M.W. Verberk
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | | | | | - Charlotte E. Teunissen
- Neurochemistry Laboratory, Department of Clinical Chemistry, VU University Medical Center (VUmc) Amsterdam University Medical Centers (AUMC) Amsterdam Netherlands
| | | | | | | | - Niels D. Prins
- Alzheimer center Amsterdam, Department of Neurology, Amsterdam Neuroscience VU University Medical Center, Amsterdam UMC Amsterdam Netherlands
| | | | - Philip Scheltens
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Bart N.M. Van Berckel
- Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Wiesje M. van der Flier
- Alzheimer Center & Department of Neurology, Amsterdam Neuroscience VU University Medical Center Amsterdam Netherlands
| |
Collapse
|
|
20
|
Stoops E, Verberk IM, Koelewijn AMW, Vanbrabant J, Vanderstichele HM, Teunissen CE. O2-05-03: CHARACTERIZATION AND TRANSFER OF A NOVEL PLASMA Aβ1-42/Aβ1-40 SIMOA ASSAY FOR INTEGRATION INTO THE CLINIC. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.4477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
| | - Inge M.W. Verberk
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience; Vrije Universiteit Amsterdam, Amsterdam UMC; Amsterdam Netherlands
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience; Vrije Universiteit Amsterdam, Amsterdam UMC; Amsterdam Netherlands
| | - Anne MW. Koelewijn
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience; Vrije Universiteit Amsterdam, Amsterdam UMC; Amsterdam Netherlands
| | | | | | - Charlotte E. Teunissen
- Amsterdam Neuroscience; Amsterdam Netherlands
- Neurochemistry Laboratory, Department of Clinical Chemistry; VU University Medical Center (VUmc), Amsterdam University Medical Centers (AUMC); Amsterdam Netherlands
| |
Collapse
|
|
21
|
Verberk IM, Thijssen E, Koelewijn AMW, Scheltens P, van der Flier WM, Stoops E, Vanderstichele HM, Teunissen CE. F2-07-04: PLASMA AMYLOID BETA 1-42 AND 1-40 MEASURED BY A NOVEL SIMOA ASSAY AS A DIAGNOSTIC TOOL FOR ALZHEIMER'S DISEASE PATHOLOGY. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.4443] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Inge M.W. Verberk
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience; Vrije Universiteit Amsterdam, Amsterdam UMC; Amsterdam Netherlands
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience; Vrije Universiteit Amsterdam, Amsterdam UMC; Amsterdam Netherlands
| | - Elisabeth Thijssen
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience; Vrije Universiteit Amsterdam, Amsterdam UMC; Amsterdam Netherlands
| | - Anne MW. Koelewijn
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience; Vrije Universiteit Amsterdam, Amsterdam UMC; Amsterdam Netherlands
| | - Philip Scheltens
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience; Vrije Universiteit Amsterdam, Amsterdam UMC; Amsterdam Netherlands
| | - Wiesje M. van der Flier
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience; Vrije Universiteit Amsterdam, Amsterdam UMC; Amsterdam Netherlands
| | | | | | - Charlotte E. Teunissen
- Neurochemistry laboratory, Department of Clinical Chemistry; VU University Medical Center (VUmc), Amsterdam University Medical Centers (AUMC); Amsterdam Netherlands
| |
Collapse
|
|
22
|
Verberk IM, Thijssen E, Koelewijn AM, Scheltens P, van der Flier WM, Stoops E, Teunissen CE, Vanderstichele HM. F1‐05‐01: LAB‐RELATED PRE‐ANALYTICAL FACTORS INFLUENCING PLASMA AMYLOID BETA CONCENTRATIONS. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.4385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Inge M.W. Verberk
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Elisabeth Thijssen
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Anne M.W. Koelewijn
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Philip Scheltens
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Wiesje M. van der Flier
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience VU University Medical Center, Amsterdam UMC Amsterdam Netherlands
| | | | - Charlotte E. Teunissen
- Department of Clinical Chemistry, Neurochemistry Laboratory and Biobank, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | | |
Collapse
|
|
23
|
Teunissen CE, Verberk IM, Bridel C. F2‐02‐04: NEUROFILAMENTS TO MEASURE TREATMENT EFFICACY IN MS. Alzheimers Dement 2018. [DOI: 10.1016/j.jalz.2018.06.2618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- Charlotte E. Teunissen
- VU University Medical CenterAmsterdamNetherlands
- Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam NeuroscienceVU University Medical CenterAmsterdamNetherlands
| | - Inge M.W. Verberk
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam NeuroscienceVU University Medical CenterAmsterdamNetherlands
| | | |
Collapse
|
|
24
|
Verberk IM, Slot RE, Verfaillie SC, Heijst H, Prins ND, Scheltens P, Teunissen CE, Flier WM. F4‐08‐01: PLASMA AMYLOID AS A PRE‐SCREENING TOOL FOR AMYLOID POSITIVITY IN SUBJECTIVE COGNITIVE DECLINE. Alzheimers Dement 2018. [DOI: 10.1016/j.jalz.2018.06.2892] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- Inge M.W. Verberk
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam NeuroscienceVU University Medical CenterAmsterdamNetherlands
| | | | | | - Hans Heijst
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam NeuroscienceVU University Medical CenterAmsterdamNetherlands
| | | | | | | | | |
Collapse
|
|
25
|
Thijssen E, Verberk IM, Vanderstichele HM, Heijst H, Scheltens P, Stoops E, Teunissen CE. O3‐09‐06: A PROTOTYPE SIMOA ASSAY QUANTIFYING PLASMA AMYLOID BETA 1‐42 AND 1‐40 ISOFORMS CAN DIFFERENTIATE PARTICIPANTS WITH AD FROM HEALTHY CONTROL SUBJECTS. Alzheimers Dement 2006. [DOI: 10.1016/j.jalz.2018.06.2824] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- Elisabeth Thijssen
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam NeuroscienceVU University Medical CenterAmsterdamNetherlands
| | - Inge M.W. Verberk
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam NeuroscienceVU University Medical CenterAmsterdamNetherlands
| | | | - Hans Heijst
- Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam NeuroscienceVU University Medical CenterAmsterdamNetherlands
| | - Philip Scheltens
- Alzheimer Center and Department of NeurologyVU University Medical Center, Amsterdam NeuroscienceAmsterdamNetherlands
| | | | | |
Collapse
|